13.11.2014 Views

Haematologica 2003 - Supplements

Haematologica 2003 - Supplements

Haematologica 2003 - Supplements

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

was associated with I.V. line, while 4 (30.8 %) were identified<br />

postoperatively. We identified several univariable correlates in<br />

MGUS patients, including family (HR-13.79, P= .014) and<br />

personal (HR-8.95, P=. 002) history of DVT, low serum albumin<br />

(HR-4.21, P=. 018) and increased white blood cells count (HR-<br />

3.41, P=. 032). IgG immunoglobulin type was protective in our<br />

analysis (HR-0.19, P=. 017). None of the patients received any<br />

type of active treatment for their disaese. In conclusion, risk for<br />

thromboembolic diseases in patients with MGUS is increased as<br />

compared to general population, and is similar to incidence in<br />

MM patients (10%). Further studies are necessary to define the<br />

mechanisms involved.<br />

098<br />

Amyloidosis and Deep Venous Thrombosis (DVT)<br />

Gordan Srkalovic, Marte A. Cameron, Lisa Rybicki and<br />

Mohamad A. Hussein<br />

Cleveland Clinic Foundation Multiple Myeloma Research Program<br />

Coagulation problems in Amyloidosis are historically associated<br />

with bleeding tendencies (mostly F X abnormalities). Increased<br />

clotting was observed in isolated cases diagnosed with low grade<br />

DIC. Problem of DVT in Amyloidosis was not systematically<br />

investigated. We evaluated frequency of DVT and risk factors for<br />

DVT in 56 consecutive Amyloidosis patients with a documented<br />

disease evaluated and followed up at our Center from 1991-2001.<br />

Data were collected in 5 categories: (a) demographics, (b) disease<br />

and treatment, (c) thrombosis case information, (d) major risk<br />

factors for thrombosis and (e) baseline laboratory data. Uni- and<br />

multivariable correlates of DVT were assessed using Kaplan-<br />

Meier analysis and Cox proportional hazards analysis. Mean age<br />

of the patients was 61.8 (range 21 – 83). Male female percentage<br />

ratio was 70/30. 30 % of the patients had high creatinine level (><br />

1.4 mg/dl). Personal or family history of DVT was recorded in<br />

1.8 and 0 % of patients, respectively. Known hypercoagulable<br />

state was present in 1 patient (1.8%). 7.6 % of patients were<br />

smokers. Of 56 patients 6 developed DVT (10.7%). Median<br />

time from diagnosis to DVT was 12.5 month (range 1-107).<br />

Treatment was given within 1.4 months (range 0-4) from the<br />

development of thrombosis. Only sites of DVT were lower<br />

extremities. No cases were associated with I.V. line. 1 (16.7 %)<br />

was identified postoperatively. We identified several univariable<br />

correlates of DVT in Amyloid patients, including age at<br />

diagnosis (HR-2.99, P=. 041), personal history of DVT (HR-47.7,<br />

P=.006), immobility (HR-11.78, P=.006). Paradoxically, presence<br />

of circulating serum M-protein had protective role in our analysis<br />

(HR-.08, 95% confidence interval .01-. 80, P=. 031). There was<br />

no correlation with the type of treatment patients was receiving.<br />

Family and personal history of DVT were also identified as risk<br />

factors in multivariable analysis of whole group (668) of patients<br />

with plasma cell dyscrasias. In conclusion, risk for<br />

thromboembolic diseases in patients with Amyloidosis is<br />

identical to one previously described for MM patients (10%).<br />

Further studies are necessary to define pathophysiological<br />

processes involved.<br />

099<br />

Disturbances of Anticoagulation and Fibrinolytic<br />

Systems in Monoclonal Gammapathies - Another<br />

Mechanism of M-protein Interference with Hemostasis.<br />

Ivan Spicka, Zuzana Rihova, Petr Cieslar, Bohumir<br />

Prochazka *<br />

Ist Department of Internal Medicine, Department of Hematology,<br />

General Faculty Hospital, Charles University, Prague, Czech rep; *<br />

National Institute of Public Health, Prague, Czech rep. Phone: +<br />

420-2- 24962551; Fax: + 42-2-297932; e-mail: spicka@cesnet.cz<br />

Monoclonal gammapathies (MG) may be associated with unique<br />

M-protein induced disturbances of either primary hemostasis or<br />

plasma coagulation. We have investigated the possible<br />

interference of M-protein with antithrombotic systems. Decrease<br />

of antithrombin III, protein C, protein S and plasminogen levels<br />

or defect of APC resistance was found in 26.5% of patients.<br />

However, higher tissue-type plasminogen activator (t-PA)<br />

activity was the most frequent abnormality. The relationship<br />

between M-protein type and concentration and frequency of<br />

antithrombotic factor abnormalities was not found. The risk of<br />

venous thrombosis was higher in patients with the defect in<br />

comparison with the unaffected group (46% vs. 22%) but the<br />

difference was not statistically significant. Bleeding<br />

complications were markedly less frequent in the group of<br />

patients with the defect of anticoagulation mechanisms (0% vs.<br />

17%). In conclusion, we have found the defects of<br />

anticoagulation and/or fibrinolytic system, analogous to wellknown<br />

disturbances in hemostatic mechanisms, in more than a<br />

quarter of patients with MG. The interference of M-protein with<br />

coagulations inhibitors and/or fibrinolytic systems could<br />

contribute to the development of thromboembolic events.<br />

100<br />

Occupation, Pesticide Exposure and Risk of Multiple<br />

Myeloma<br />

D. Baris1, D.T. Silverman1, L.M. Brown1, G.M. Swanson2,<br />

R.B. Hayes1, A.G. Schwartz3, J.M. Liff4, J.B.<br />

Schoenberg5, L. M. Pottern6, R.S. Greenberg7, P.A.<br />

Stewart1.<br />

1Div. of Cancer Epidemiology and Genetics, NCI, NIH, DHHS,<br />

Bethesda, MD; 2Cancer Center, Michigan State University, E. Lansing,<br />

MI;3Wayne State University, School of Medicine and the Karmanos<br />

Cancer Institute, Detroit, MI; 4Rollins School of Public Health, Emory<br />

University, Atlanta, GA; 5New Jersey State Department of Health,<br />

Trenton, NJ; 6Women`s Health Initiative, NIHLB, NIH, DHHS,<br />

Bethesda, MD; 7Medical University of South Carolina, Charleston, SC.<br />

In this population-based case-control study, we examined the<br />

relationship between occupation, farm history, pesticide exposure<br />

and risk of multiple myeloma among blacks and whites in the<br />

U.S. The study included 573 cases (206 blacks and 367 whites)<br />

newly diagnosed with myeloma between 1986 and 1989 and<br />

2,131 controls (967 blacks and 1,164 whites) from three U.S.<br />

geographic areas. Detailed information was obtained on sociodemographic<br />

factors, occupational and farm history, dietary<br />

factors, smoking, and medical history. Information on usual<br />

occupation and industry were coded according to standardized<br />

classification systems. A job/industry exposure matrix (JEM)<br />

was developed to estimate the level of occupational exposure to<br />

pesticides. Odds ratios (ORs) and 95% confidence intervals (CIs)<br />

for the analyses of occupational and farm history and pesticide<br />

exposure were estimated by unconditional logistic regression.<br />

Farmers and farm workers had ORs of 1.9 (95% CI=0.8-4.6) and<br />

1.4 (95% CI=0.8-2.3), respectively. An OR of 1.7 (95% CI=1.0-<br />

2.7) was observed among those who lived or worked on a farm<br />

S132

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!